Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Glaxo Lawyer Says Abbott Tried to Stifle Rivalry on Aids Drug
Bloomberg
Thursday, March 24, 2011 - 1:45pm
tags:
GSK, Abbott Laboratories, AIDS, Norvir
Steere’s Exit Could Mean Pfizer Is Serious About Changing
Forbes
Thursday, March 24, 2011 - 1:44pm
tags:
Pfizer
Sanofi to grow animal health through bolt-on buys
Reuters
Thursday, March 24, 2011 - 1:23pm
tags:
animal health, Sanofi, M&A
Watson Launches Generic Famvir
Yahoo/Zacks.com
Thursday, March 24, 2011 - 12:50pm
tags:
Watson Pharmaceuticals, generics, Famvir, genital herpes, JNJ, Cephalon
J&J’s Ethicon Unit Recalls 360,000 Surgical Drainage Products
Bloomberg
Thursday, March 24, 2011 - 12:45pm
tags:
JNJ, recalls, Ethicon
Targacept drug fails in ADHD midstage study
Yahoo/AP
Thursday, March 24, 2011 - 12:26pm
tags:
Targacept, ADHD, TC-5619
Historical Trial Data Bodes Well for Amarin
Seeking Alpha
Thursday, March 24, 2011 - 12:15pm
tags:
Amarin, AMR101
Titan Pharmaceuticals: Key Catalyst Sneaks Up on Investors
Seeking Alpha
Thursday, March 24, 2011 - 11:50am
tags:
Titan, opiod addiciton, Probuphine
Procter & Gamble, Teva to Form Consumer-Health Venture
Bloomberg
Thursday, March 24, 2011 - 9:52am
tags:
Teva Pharmaceuticals, OTC, Proctor & Gamble, P&G
Bristol-Myers melanoma drug may soon hit US market
Reuters
Thursday, March 24, 2011 - 9:37am
tags:
melanoma, FDA, Bristol-Myers Squibb, ipilimumab
Biosimilar Drugs to Generate $3.7 Billion by 2015, Analyst Says
Bloomberg
Thursday, March 24, 2011 - 9:34am
tags:
biosimilars
Boehringer, Pfizer’s Spiriva Bests Glaxo Drug for Lung Disorder
Bloomberg
Thursday, March 24, 2011 - 9:33am
tags:
Boehringer Ingelheim, Pfizer, Spiriva, GSK, COPD, Serevent
Sanofi Profiles Zalicus Drug Today, a Positive Sign for Investors
Seeking Alpha
Thursday, March 24, 2011 - 9:22am
tags:
Sanofi, Zalicus, Amgen, Novartis, ophthalmology, Prednisporin
Genzyme Fabrazyme shortage to worsen
Bizjournals.com
Thursday, March 24, 2011 - 9:20am
tags:
Genzyme, Fabrazyme, Fabry's disease
Bristol-Myers: A $44 Billion High-Yield Stock That Could Be in Trouble
Seeking Alpha
Thursday, March 24, 2011 - 9:19am
tags:
Bristol-Myers Squibb
GSK won’t pursue Avodart for prostate cancer
Bizjournals.com
Thursday, March 24, 2011 - 9:18am
tags:
prostate cancer, GSK, Avodart
Health-Care Overhaul Law Has Tumultuous First Year
WSJ Online
Wednesday, March 23, 2011 - 11:20am
tags:
healthcare reform
Payers may balk at Makena pricing, KV says
Fierce Pharma
Wednesday, March 23, 2011 - 11:15am
tags:
Makena, KV Pharmaceutical, drug pricing, premature birth
Omeros' eye surgery drug meets midstage study goals
Yahoo/AP
Wednesday, March 23, 2011 - 11:13am
tags:
Omeros, cataracts
J&J Faces $360M Penalty Over Risperdal Marketing
Pharmalot
Wednesday, March 23, 2011 - 10:34am
tags:
Risperdal, JNJ, Ortho-McNeil-Janssen

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.